2016 American Transplant Congress » Concurrent Session: Hepatic Malignancies

4:30pm-4:42pm

Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma in Cirrhotic Livers.

M. Samoylova, N. Mehta, J. Roberts, F. Yao.

4:42pm-4:54pm

Pre-Transplant Loco-Regional Therapy for Hepatocellular Carcinoma and Post-Transplant Outcomes: A National Study.

M. Nazzal,¹ J. Chen,¹ K. Lentine,¹ M. Schnitzler,¹ J. Tuttle-Newhall,² C. Varma,¹ A. Taha,¹ A. Said,¹ H. Xiao,¹ H. Randall.¹

4:54pm-5:06pm

Traditionally Unacceptable Organs Promote Liver Transplantation in Patients with Long Waiting Times in the Share 35 Era.

E. Siskind,¹ T. MacDonald,² R. Barth,¹ J. LaMattina,¹ D. Bruno,¹ S. Hanish.¹

5:06pm-5:18pm

Hepatocellular Carcinoma Decreases Chance of Successful HCV Therapy in the Current Era.

S. Prenner, L. VanWagner, L. Kulik.

5:18pm-5:30pm

Is Pretransplant Determination of Hepatocellular Carcinoma Tumor Grade Using Needle Biopsy Reliable for Transplant Candidate Selection? Analysis of 217 Liver Transplant Recipients.

C. Court, M. Harlander-Locke, D. Markovic, F. Kaldas, A. Zarrinpar, D. Farmer, S. Sho, J. Tomlinson, J. Hiatt, R. Busuttil, V. Agopian, D. Lu, S. Raman.

5:30pm-5:42pm

The Influence of Rising Lab MELD on Vascular Invasion in HCC.

K. Halazun, E. Przybyszewski, E. Verna, B. Samstein, A. Fox, R. Brown, J. Emond.

5:42pm-5:54pm

Visceral Adiposity Is Associated with Increased Recurrence of Hepatocellular Carcinoma Following Liver Transplantation.

A. Mathur, L. Boyangzi, M. Prince, J. Guarrera, B. Samstein, A. Griesemer, K. Halazun, T. Kato, J. Emond.